Recombinant Rituximab anticorps

N° du produit ABIN7482277

Détail du produit anti-Rituximab anticorps

Antigène: Rituximab

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Rituximab est non-conjugé

Application: ELISA, Lateral Flow (LF)

Fonction: Anti-Rituximab Antibody (MALS verified)

Attributs du produit: Anti-idiotypic Antibodies

Classe de qualité: MALS verified

Immunogène: Anti-Rituximab Antibody (ABIN7482277) are expressed from human 293 cells (HEK293).

Information d'application

Indications d'application: This antibody can be paired with other CD20 antibodies to detect CD20 in sandwich ELISA or LFA assay.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Stock: -20 °C

Détails sur Rituximab

Antigène: Rituximab

Abstract: Rituximab Produits

Classe de substances: Antibody

Sujet: Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids, Anti-Rituximab Antibodies (RIB-Y35c) is the monoclonal antibody of Rituximab expressed with human HEK293 cells.